Related Experiment Video
Updated: Aug 9, 2026

05:53
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
[Gilbert's syndrome: a clinicogenetic trial]
Terapevticheskii Arkhiv
|April 15, 2006
Summary
This study improves Gilbert's syndrome (GS) diagnosis using genetic and functional tests. Genetic analysis revealed specific gene variations, aiding in classifying GS variants and predicting drug responses.
Area of Science:
- Medical Genetics
- Hepatology
- Clinical Diagnostics
Background:
- Gilbert's syndrome (GS) is a common genetic disorder affecting bilirubin metabolism.
- Accurate diagnosis of GS is crucial for differentiating it from other liver conditions.
Purpose of the Study:
- To enhance the diagnostic accuracy of Gilbert's syndrome (GS).
- To integrate functional and genetic examination methods for improved GS detection.
Main Methods:
- Diagnosis of GS in 88 patients (aged 15-72) using clinical and genetic testing.
- Genotyping focused on the promoter region of the uridinediphosphateglucuroniltransferase gene.
Main Results:
- Genetic analysis identified variations in the uridinediphosphateglucuroniltransferase gene promoter.
- Homozygous carriers exhibited higher baseline bilirubin and distinct functional test responses, often with essential tremor.
- Heterozygous patients frequently presented with latent GS.
Conclusions:
- Four clinical variants of GS identified: dyspeptic, asthenovegetative, jaundice, and latent.
- A low-caloric diet followed by phenobarbital improved test sensitivity and specificity.
- Proposed clinical classification of GS and identified pharmacokinetic alterations for predicting adverse drug reactions.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
